AKT1 and ovarian carcinoma: Furthermore, when AKT1 was knocked down in ovarian cancer cells with depletion of circPLEKHM3, the upregulation of Wnt/β-catenin that resulted from downregulation of circPLEKHM3 was dramatically attenuated; the cell phenotypes were also rescued by decreasing cell proliferation and migration.